Zag Bio Began Clinical Trials for Type 1 Diabetes Drug
The company has initiated its Phase 1b/2a trial to evaluate the safety and pharmacology of ZAG-101.
Live Poll
Do you trust that new medical research will successfully address the root causes of autoimmune diseases?